Role of viral infection in the aetiology of multiple sclerosis: Status of current knowledge and therapeutic implications

CNS Drugs

Volumn 12, Issue 1, 1999, Pages 1-7

  Berti, Rossana ^a   Jacobson, Steven ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CENTRAL NERVOUS SYSTEM DISEASE; DEMYELINATING DISEASE; HUMAN; HUMAN HERPESVIRUS 6; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; RETROVIRUS; VIRUS INFECTION; VIRUS PATHOGENESIS;

EID: 0032800734     PISSN: 11727047     EISSN: None     Source Type: Journal    
DOI: 10.2165/00023210-199912010-00001     Document Type: Article

References (62)

1. Vyse TJ, Todd JA. Genetic analysis of autoimmune disease. Cell 1996; 85 (3): 311-8
2. Wucherpfenning KW, Strominger JL. Molecular mimicry in T- cell mediated autoimmunity: viral peptides activated human T cell clones specific for myelin basic protein. Cell 1995; 80: 695-705.
3. Marrack P, Kappler J. Subversion of the immune system by pathogens. Cell 1994; 76: 323-32
4. Lynch SG, Rose JW. Multiple sclerosis. Dis Mon 1996; 42 (1): 1-55
5. Kurtzke JF. MS epidemiology world wide. One view of current status. Acta Neurol Scand 1995; Suppl. 161: 23-33
6. Cook SD. Multiple Sclerosis and viruses. Mult Scler 1997; 3 (6): 388-9
7. Kurtzke JF, Hyllested K, Heltberg A. Multiple sclerosis in the Faroc Islands: transmission across four epidemics. Acta Neurol Scand 1995; 91: 321-5
8. Rohowsky-Kochan C, Dowling PC, Cook SD. Canine distemper virus-specific antibodies in multiple sclerosis. Neurology 1995; 45 (8): 1554-60
9. Brown JS Jr. Geographic correlation of multiple sclerosis with tick-borne diseases. Mult Scler 1996; 1: 257-61
10. MacGregor HS, Latiwonk QI. Search for the origin of multiple sclerosis by first identifying the vector. Med Hypothesis 1992; 37: 67-73
11. Soldan SS, Berti R, Salem N. Association of human herpes virus 6 (HHV-6) with multiple sclerosis: increased IgM response to HHV-6 early antigen and detection of serum HHV-6 DNA. Nature Med 1997 Dec; 3(12): 1394-7
12. Cook SD, Rohowsky-Kochan C, Bansil S. Evidence for multiple sclerosis as an infectious disease. Acta Neurol Scand 1995; Suppl. 161: 34-42
13. Tytgat GN. Helicobacter pylori: causal agent in peptic ulcer disease? Conclusion. J Gastroenterol Hepatol 1991; 6 (2): 139-40
14. Pachner AR, Duray P, Steere AC. Central nervous system manifestations of Lyme disease. Arch Neurol 1989 Jul; 46 (7): 790-5
15. Gerber MA, Sedgwich AK, MacAlister TJ. The aetiological agent of cat scratch disease. Lancet 1985 Jun 1; 1 (8440): 1236-9
16. Volker ter Meulen V, Katz M. The proposed viral aetiology of multiple sclerosis and related demyelinating diseases. In: Raine CS, Mc Farland HF, Tourtellotte WW, editors. Multiple sclerosis clinical and pathogenetic basis. Cambridge: Chapman & Hall, 1997: 287-305
17. Pease LR, Murphy WH. Co-infection by lactic dehydrogenas virus and C-type retrovirus elicits neurological disease. Nature 1980; 286: 398-400
18. Johnson RT. The virology of demyelinating diseases. Ann Neurol 1994; 36: S54-60
19. Osame M, Usuku K, Izumo S, et al. HTLV 1 associated myelopathy, a new clinical entity. Lancet 1986; 11: 1031-2
20. Rice GP. Virus-induced demyelination in man: models for multiple sclerosis. Curr Opin Neurol Neurosurg 1992; 5 (2): 188-94
21. Margulis MS, Soloviev VD, Shubladze AK. Aetiology and pathogenesis of acute sporadic disseminated encephalomyelitis and multiple sclerosis. J Neurol Neurosurg Psychiatry 1946; 9: 63-74
22. Bychkova EN. Viruses isolated from patients with encephalomyelitis and multiple sclerosis. I. Pathogenetic and antigenic properties. Fed Proc Transl 1965; Suppl. 24 (4): 742-4
23. Field EJ, Miller H, Russel DS. Observation of glial inclusion bodies in case of acute disseminated sclerosis. J Clin Pathol 1962; 15: 278-84
24. Gudnadottir M, Helgadottir H, Bjarnason O, et al. Virus isolated from the brain of a patient with multiple sclerosis. Exp Neurol 1964; 9: 85-95
25. Norrby E. Viral antibodies in multiple sclerosis. Prog Med Virol 1978; 24: 1-39
26. Carp RI, Licursi PC, Merz PA, et al. Decrease percentages of polimorphonuclear neutrophilis in mouse peripheral blood after inoculation with material from multiple sclerosis patients. J Exp Med 1972; 136: 618-29
27. ter Meulen V, Koprowski H, Iwasaki Y, et al. Fusion of cultured multiple-sclerosis brain cells with indicator cells: presence of nucleocapsid and virion and isolation of parainfluenza-type virus. Lancet 1972; 1: 1-5
28. Field EJ, Cowshall S, Narang HK, et al. Viruses in multiple sclerosis? Lancet 1972; 11: 280-1
29. Cosby SL, McQuaid S, Taylor MJ, et al. Examination of eight cases of multiple sclerosis and 56 neurological and non-neurological controls for genomic sequences of measles virus, canine distemper virus, simian virus 5 and rubella virus. J Gen Virol 1989; 70: 2027-36
30. Mitchell DN, Porterfield JS, Micheletti R, et al. Isolation of an infectious agent from bone-marrows of patients with multiple sclerosis. Lancet 1978; 11: 387-90
31. Wrobleska Z, Gilden D, Devlin M, et al. Cytomegalovirus isolation from a chimpanzee with acute demyelinating disease after inoculation of multiple sclerosis brain cells. Infect Immun 1979; 25: 1008-15
32. Burks JS, Devald BL, Jankovsky LD, et al. Two coronaviruses isolated from central nervous system tissue of two multiple sclerosis patients. Science 1980; 209: 933-4
33. Melnick JL, Seidel E, Inoue YK, et al. Isolation of virus from the spinal fluid of three patients with multiple sclerosis and one with amyotrophic lateral sclerosis. Lancet 1982; 1: 830-3
34. Vagabov RMA, Skortsoa TM, Gofman YP, et al. Isolation of the tick borne encephalitis virus from a patient with multiple sclerosis. Acta Virol 1982; 26 (5): 403
35. Koprowski H, DeFreitas EC, Harper ME, et al. Multiple sclerosis and human T cell lymphotropic retroviruses. Nature 1985; 318: 154-60
36. Perron H, Geny C, Laurent A, et al. Leptomeningeal cell line from multiple sclerosis with reverse transcriptase activity and viral particles. Res Virol 1989; 140: 551-61
37. Bergstrom T, Andersen O, Vahlne A. Isolation of herpes simplex virus type 1 during first attack of multiple sclerosis. Ann Neurol 1989; 26: 283-5
38. Perron H, Suh M, Lalande B, et al. Herpes simplex virus ICPO and ICP4 immediate early proteins strongly enhance expression of a retrovirus harbored by a leptomeningeal cell line from a patient with multiple sclerosis. J Gen Virol 1993; 74: 65-72
39. Munch M, Hvas J, Christensen T, et al. The implication of Epstein-Barr virus in multiple sclerosis a review. Acta Neurol Scand 1997; Suppl 169: 59-64
40. Challoner PB, Smith KT, Parker JD, et al. Plaque associated expression of human herpes virus 6 in multiple sclerosis. Proc Natl Acad Sci U S A 1995; 92: 7440-4
41. Sola P, Merelli E, Marasca R, et al. Human herpesvirus 6 and multiple sclerosis: survey of anti-HHV-6 antibodies by immunofluorecsence analysis and of viral sequences by polymerase chain reaction. J Neurol Neurosurg Psychiatry 1993; 56: 917-9
42. Perron H, Garson JA, Bedin F, et al. Molecular identification of a novel retrovirus repeatedly isolated from patients with multiple sclerosis. Proc Natl Acad Sci U S A 1997; 94: 7583-8
43. Dalgleish AG. Viruses and multiple sclerosis. Acta Neurol Scand 1997; Suppl. 169: 8-15.
44. Brahic M, Bureau JF. Multiple sclerosis and retroviruses. Ann Neurol 1997; 42: 984-5
45. Salahuddin SZ, Ablashi DV, Markham PD, et al. Isolation of a new virus, HBLV, in patients with lymphoprolipherative disorders. Science 1986; 234 (4776): 596-601
46. Yamanishi K, Okuno T, Shiraki M, et al. Identification of human herpesvirus-6 as a causal agent for exanthem subitum. Lancet 1988; 1: 1065-7
47. Drobyski WR, Knox KK, Majewski D, et al. Fatal encephalitis due to variant B human herpesvirus-6 infection in a bone marrow-transplant recipient. N Engl J Med May 1994; 330 (19): 1356-60
48. Knox KK, Carrigan DR. Active human herpesvirus (HHV-6) infection of the central nervous system in patients with AIDS. J Acquir Immune Defic Syndr Hum Retrovirol 1995; 9: 69-73
49. Knox KK, Harrington DP, Carrigan DR. Fulminant human herpesvirus six encephalitis in a human immunodeficiency virus-infected infant. J Med Virol 1995; 45: 288-92
50. Mackenzie IRA, Carrigan DR, Wiley CA. Chronic myelopathy associated with human herpesvirus-6. Neurology 1995; 45: 2015-7
51. Caserta MT, Hall CB, Schnabel K, et al. Neuroinvasion and persistence of human herpesvirus 6 in children. J Infect Dis 1994; 170: 1586-9
52. He J, McCarthy M, Zhou Y, et al. Infection of primary human fetal astrocytes by human herpesvirus 6. J Virol Feb 1996; 1296-300
53. Secchiero P, Carrigan DR, Asano Y, et al. Detection of human herpesvirus 6 in plasma of children with primary infection and immunosuppressed patients by polymerase chain reaction. J Infect Disease 1995; 171: 273-80
54. Martin C, Enbom M, Soderstrom M, et al. Absence of seven human herpesviruses, including HHV-6, by polymerase chain reaction in CSF and blood from patients with multiple sclerosis. Acta Neurol Scand 1997 May; 95 (5): 280-3
55. Mayne M, Krishnan J, Metz L, et al. Infrequent detection of human herpesvirus 6 DNA in peripheral blood mononuclear cells from multiple sclerosis patients. Ann Neurol Sept 1998; 44 (3): 391-4
56. Peters WP, Kufe D, Schlom J, et al. Biological and biochemical evidence for an interaction between Marck's disease herpesvirus and avian leukosis virus in vivo. Proc Natl Acad Sci U S A 1973; 70: 3175-8
57. Chinnadurai G. Modulation of HIV-enhancer activity by heterologus agents: a mini review. Gene 1991; 101: 165-70
58. Sommerlund M, Pallesen G, Moller-Larsen A, et al. Retrovirus-like particles in an Epstein-Barr virus producing cell line derived from a patient with chronic progressive myelopathy. Acta Neurol Scand 1993; 87: 71-6
59. IFNB Multiple Sclerosis Study Group. Interferon beta 1-b is effective in relapsing-remitting multiple sclerosis. Neurology 1993; 43: 655-61
60. Durelli L, Bongioanni MR, Cavallo R, et al. Chronic systemic high-dose recombinant interferon alfa-2a reduces exacerbation rate, MRI signs of disease activity, and lymphocyte interferon gamma production in relapsing-remitting multiple sclerosis. Neurology 1994; 44: 406-13
61. Lycke J, Svennerholm B, Hjelmquist, et al. Acyclovir treatment of relapsing-remitting multiple sclerosis. J Neurol 1996; 243: 214-24
62. Mims CA. Viral aetiology of diseases of obscure origin. Br Med Bull 1985; 41: 63-9